More hair in the shower drain. Thinning spots along the part. Sound familiar? Early-stage androgenetic thinning is one of the few scalp conditions where acting early dramatically changes long-term outcomes. Unlike advanced baldness, which requires transplant surgery to physically relocate existing follicles, early thinning still has active follicles waiting to be triggered. PRP targets exactly those follicles.
Seven Medical Aesthetics specializes in finding patients PRP actually helps. Equally honest about when it won’t. The difference between a good outcome and wasted money almost always comes down to one thing: proper candidacy assessment before anyone picks up a centrifuge.
Three things, then. How PRP’s growth factors trigger follicular regrowth at the cellular level. Whether you’re actually a candidate (not just a hopeful one). And why the right approach is PRP combined with proven medications, protocols aligned with Johns Hopkins, Mayo Clinic, and Cleveland Clinic, because clinical evidence beats marketing every time.
How PRP Actually Works: Growth Factors Explained
Simpler than it sounds. Your blood contains platelets loaded with multiple proteins called growth factors, and when we concentrate that plasma and inject it into the scalp, we’re delivering three distinct biological signals to follicles simultaneously, each one targeting a different mechanism in the hair thinning cascade.
PDGF (Platelet-Derived Growth Factor) tells dormant follicle cells to wake up and divide. Think of it as a cellular alarm clock. Your follicles contain progenitor cells sitting in a resting state, and PDGF signals them to resume proliferating.
VEGF (Vascular Endothelial Growth Factor) promotes capillary bed formation throughout the scalp microvasculature surrounding each follicle. More circulation means more oxygen and nutrients delivered directly to the follicle base. Without adequate perfusion, even follicle structures that have received the PDGF activation signal can’t produce healthy strands because the raw materials simply aren’t reaching them.
FGF-7 (Fibroblast Growth Factor-7) activates a signaling pathway that prolongs the active (anagen) phase and shortens the telogen resting phase of your follicular cycle. That ratio shift drives visible density improvements over months. Slower than patients expect. Also more durable than most single-mechanism treatments.
The combination matters because single-mechanism treatments like topical minoxidil alone address one pathway. PRP addresses all three simultaneously. Clinical evidence consistently shows PRP outperforming monotherapy. You’re not just activating dormant follicles, you’re improving their blood supply and extending their productive cycle at the same time.
Who Should Get PRP: Candidacy Clarity
We differ from most providers here. We’ll tell you who benefits. And who won’t.
PRP works best for Norwood stages 1-3, visible thinning with active follicles still present. Both male and female pattern alopecia respond to PRP. Men tend to see stronger density gains per session. A 2024 meta-analysis in the Journal of Cosmetic Dermatology found follicular density outcomes consistently stronger in male-only trials than in mixed-sex cohorts, likely because men with androgenetic alopecia carry more DHT-responsive follicle populations in affected zones, making PRP’s platelet signaling more potent per session. Women benefit too. Just at a somewhat lower magnitude.
Age doesn’t matter. Coverage does. Do you still have strands in the thinning area, even thinner than before? If yes, PRP has follicles to work with.
PRP shows minimal response for Norwood stages 4-7 (advanced baldness), where follicles have been destroyed by prolonged DHT sensitivity. Nothing to stimulate. The follicles are gone. Not a PRP failure. The mismatch is this: when androgenetic miniaturization has permanently destroyed follicle populations through years of progressive dihydrotestosterone exposure, the appropriate intervention is transplant surgery, which physically relocates viable donor follicles from density-rich scalp regions into bald recipient zones. For thinning with intact follicle structures, PRP.
Complete baldness for years? PRP won’t recover that coverage. But if you’re at Norwood 1-3, with strands still visible in the thinning zone, the prospective research across multiple meta-analyses is fairly consistent about meaningful density improvement given appropriate candidacy and treatment protocol. We say this in every consultation, not because patients want to hear it, but because treating someone who isn’t a candidate wastes their money and erodes trust. We’d rather lose a consult to honesty than keep one through false hope.
Quick self-assessment: Do you have visible thinning but still coverage in the area? If yes, PRP. Complete baldness for years, by contrast, points toward transplant surgery, since the follicle populations required for platelet stimulation have been permanently destroyed by prolonged androgenetic exposure and progressive DHT-driven miniaturization. Uncertain about staging? A clinical evaluation at our Folsom location establishes your Norwood classification accurately and outlines your candidacy options within a single session.
Timeline: Real Expectations
The timeline is where most patients struggle, and it’s where we spend the most time during consultations. That starts with day-of realities. Scalp injections involve stinging or burning sensations, which most patients find very manageable with local numbing, and clinical data confirms that virtually all patients feel some scalp sensation during injection, with about a quarter experiencing mild tenderness that lingers a few hours beyond average. For 24-48 hours after treatment, the scalp may feel tender and slightly sensitive, similar to mild sunburn. Normal. Most people are completely comfortable within a few days.
Weeks 2-6: Temporary Shedding Phase
Some patients notice accelerated shedding beginning 2-6 weeks after their first session. More accumulating in the shower drain, more on the brush, sometimes noticeable on the pillow. This is a positive signal, not a warning sign. The growth factor surge activates the follicular cycle, triggering a temporary telogen effluvium that clears older miniaturized strands to make room for stronger regrowth. Those weaker hairs are being shed precisely because follicle structures are waking up. This phase runs 2-4 weeks. We tell patients upfront, and we document it during the consultation: this is the phase where most patients second-guess the whole process, usually around week 3 or 4 when the effluvium seems worse than before they started. Completely understandable reaction. Also the clearest signal that biostimulation is working.
Weeks 8-12 (2-3 Months): Early Improvements Visible
By this stage, most patients tell us they notice reduced shedding before anything shifts in the mirror. Less accumulating in the drain after washing, less on the brush. Some observe fine new strands emerging along the hairline or part line (vellus or baby hairs), signaling follicle structures cycling back into active regrowth. The scalp may feel slightly denser to the touch before visual improvement becomes obvious to anyone else. Research documents varying outcomes at this stage, with some studies recording 13.2% density gains at 5 months and others 7.7% at 12 weeks. First milestone. Early confirmation. Follicular activity is measurably underway. Full results aren’t visible yet, but the trajectory is unmistakably positive.
Months 4-6: Full Visible Results
Complete PRP response, six months in, looks like this: clinical evidence shows a 31% average increase in follicular density after 6 months, based on a 2024-2025 meta-analysis covering 1,826 patients across 24 randomized controlled trials.
That average masks a meaningful range of individual outcomes, driven by candidacy, treatment protocol quality, combination with proven medications, and the timing of intervention relative to follicle miniaturization progression. Some patients in those trials saw 50% improvement or better. Others landed around 10-15%. One randomized trial documented a mean increase of 33.6 additional hairs in the target area and 45.9 hairs per cm² versus baseline at follow-up.
Real numbers. Not projections from patient surveys or promotional materials, but verified follicle counts from controlled trial conditions measured against placebo cohorts. Countable.
Months 6+: Plateau Without Maintenance
Results stabilize at peak density. Without booster sessions every 6-12 months, gains gradually recede as the underlying androgenetic process resumes without platelet-derived counteraction. With a consistent maintenance regimen, outcomes hold indefinitely. Plan for it. PRP isn’t a one-time procedure like transplant surgery. It requires the same ongoing commitment as finasteride and minoxidil: managing the underlying pathology rather than resolving it permanently.
Why PRP Plus Medication Works Best
PRP stimulates regrowth. Minoxidil and finasteride prevent loss. Completely different mechanisms, which means they’re not competing for the same biological target.
PRP activates dormant follicles. Minoxidil acts as a vasodilator, improving scalp perfusion and extending the anagen phase. Finasteride inhibits 5-alpha reductase, blocking dihydrotestosterone production at the source. Three mechanisms. Three separate entry points into the androgenetic cascade, targeting growth factor stimulation, scalp vasodilation, and DHT suppression from angles no single treatment can address when applied in isolation.
The clinical data is clear: patients using PRP combined with finasteride showed 16.8% greater improvement in follicular density compared to those using minoxidil and finasteride alone after 6 months.
Why? Because PRP addresses platelet-derived stimulation, a mechanism that medication simply doesn’t reach. Complementary. Not redundant.
This is how Johns Hopkins, Mayo Clinic, and Cleveland Clinic approach follicular restoration. Combined protocols yield superior outcomes compared to any monotherapy regimen, and the evidence is consistent enough that we stopped framing PRP as an “alternative” approach years ago. At Seven Medical, we recommend adjuvant treatment when the evidence supports it. Integrated therapy for optimal outcomes. That’s what works clinically.
Candidacy Self-Check and Next Steps
Quick assessment: Can you check three of these boxes?
- You have visible thinning but still coverage in the area
- You understand results take 4-6 months to fully emerge
- You’re open to combining PRP with minoxidil/finasteride for best results
- You’re interested in maintenance sessions to sustain gains
If you checked three or more, PRP is likely a strong option for you.
A consultation isn’t a sales call, it’s an assessment. We’ll evaluate your specific Norwood stage, discuss your goals, and determine whether PRP is actually the right choice for your situation. We’re equally likely to recommend you’re not a candidate if the evidence points elsewhere. That’s how clinical practice works.
Conclusion
PRP offers real, clinically-verified benefits for early-stage androgenetic thinning, but only for appropriate candidates. Grasping the growth factor mechanisms, candidacy thresholds, and adjuvant medication protocols transforms PRP from a marketed “miracle” into a defensible clinical decision, one grounded in peer-reviewed evidence rather than promotional copy.
Seven Medical Aesthetics specializes in candidacy assessment and integrated treatment for Folsom residents and surrounding communities. Our RN founders understand the science behind these recommendations, not as a marketing talking point, but as the clinical foundation underpinning every decision we make. Starting treatment at Norwood 1-2 versus waiting until stages 4-5 produces dramatically different outcomes. We see that gap regularly.
Don’t wait. If you’re in the early stages of androgenetic thinning, the follicular window closes as miniaturization progresses. Book a complimentary consultation at our Folsom location, where we’ll evaluate your specific Norwood stage, walk through the clinical evidence for your candidacy, and tell you directly whether PRP is the right intervention or whether a different treatment approach makes more sense for your situation right now.
